DEVELOPMENT AND IN-VITRO CHARACTERISATION OF CHITOSAN LOADED PACLITAXEL NANOPARTICLE

Authors

  • Tumpa Sarkar GIPS
  • Abdul Baquee Ahmed

DOI:

https://doi.org/10.22159/ajpcr.2016.v9s3.12894

Abstract

ABSTRACT
Objectives: To meet the above aim the following objectives are undertaken: (1) Preparation of paclitaxel (PTX) loaded nanoparticles by different
techniques, (2) In-vitro evaluations of the drug loaded nanoparticles and selection of optimized batch.
Methods: PTX loaded chitosan nanoparticles were prepared by Ionic-crosslinking technique. In this technique, chitosan was dissolved in 0.25%v/v
acetic acid solution. To this above solution 0.84%v/v, glutaraldehyde solution was added dropwise under high-speed homogenizer at 17000 rpm for
1 hr.
Result: Particle size of prepared nanoparticle formulations was found to be 345.175±5.66-815.125±8.355 nm with low PDI between 0.456. The
maximum entrapment of drug was found to be 88.57±2.533% with formulation F5. In-vitro release studies of the F5 formulation showed 57.8±1.735%
release of drug after 24 hrs.
Conclusion: The prepared nanoparticles were evaluated for its particle size, zeta potential, drug entrapment efficiency, in-vitro drug release study,
and surface morphology studies by scanning electron microscopy. The results of Fourier transform infrared studies of 1:1 physical mixture of drug and
excipients confirmed the absence of incompatibility. Thus, the study concludes that PTX loaded nanoparticles were developed successfully by ionic
crosslinking method, which is expected to enhance the oral bioavailability of PTX.
Keywords: Paclitaxel, Nanoparticles, Chitosan, Ionic-crosslinking, In-vitro release.

Downloads

Download data is not yet available.

References

Langer R. Biomaterials in drug delivery and tissue engineering: One laboratory’s experience. Acc Chem Res 2000;33(2):94-101.

Bhadra D, Bhadra S, Jain P, Jain NK. Pegnology: A review of PEG-ylated systems. Pharmazie 2002;57(1):5-29.

Yao HJ, Ju RJ, Wang XX, Zhang Y, Li RJ, Yu Y, et al. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 2011;32(12):3285-302.

Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 2010;5:669-77.

Mikos AG, Lyman MD, Freed LE, Langer R. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994;15(1):55-8.

Muhammed Rafeeq PE, Junise V, Saraswathi R, Krishnan PN, Dilip C. Development and characterization of chitosan nanoparticles loaded with isoniazid for the treatment of tuberculosis. Res J Pharm Biol Chem Sci 2010;1(4):383-90.

Ahmed AB, Nath LK. Drug-excipients compatibility studies of nicorandil in controlled release floating tablet. Int J Pharm Pharm Sci 2014;6(2):468-75.

Yadav HK, Nagavarma BV, Ayaz A, Vasudha L, Shivakumar HG. Different techniques for preparation of polymeric nanoparticles - A review. Asian J Pharm Clin Res 2012;5 Suppl 3:16-23.

Patil Y, Sadhukha T, Ma L, Panyam J. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J Control Release 2009;136(1):21-9.

Thangaraja A, Savitha V, Jegatheesan K. Preparation and characterisation of Polyethylene glycol coated silica nanoparticles for drug delivery application. IJNA 2010;4(1):31-8.

Zhu Z, Li Y, Li X, Li R, Jia Z, Liu B, et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: Preparation and antitumor activity in vivo. J Control Release 2010;142(3):438-46.

Published

01-12-2016

How to Cite

Sarkar, T., and A. B. Ahmed. “DEVELOPMENT AND IN-VITRO CHARACTERISATION OF CHITOSAN LOADED PACLITAXEL NANOPARTICLE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 9, Dec. 2016, pp. 145-8, doi:10.22159/ajpcr.2016.v9s3.12894.

Issue

Section

Original Article(s)